Diagnosis and Management of Testicular Cancer: The European Point of View
This book presents the views of leading European experts on the diagnosis and management of testicular cancer, with coverage of current hot topics in the field. It opens by providing an overview of the recommendations in the most recent consensus paper from the European Germ Cell Cancer Consensus Gr...
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Cham
Springer International Publishing
2015
|
| Ausgabe: | 1st ed. 2015 |
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | This book presents the views of leading European experts on the diagnosis and management of testicular cancer, with coverage of current hot topics in the field. It opens by providing an overview of the recommendations in the most recent consensus paper from the European Germ Cell Cancer Consensus Group, which is based on interdisciplinary cooperation among urologists, medical oncologists, radio-oncologists, pathologists, and basic scientists. The remainder of the book focuses on areas of controversy in the diagnosis, treatment, and follow-up of testicular cancer. In each case the evidence base is discussed and results from the most recent studies are reviewed, drawing attention to new findings that might alter treatment recommendations. The treatment-related chapters cover a broad range of issues, including the best approach in patients with poor-prognosis and recurrent disease and those with long-term toxicities. Relevant aspects of survivorship care are also addressed. The book will help clinicians and practitioners to achieve the goals of minimizing therapy and its side-effects without reducing efficacy in low stage disease, improving the cure rate in advanced disease, and enhancing follow-up and long-term survivorship |
| Beschreibung: | Part I: Overview of the latest recommendations of the European Germ Cell Cancer Group -- Part II: Special topics about controversial aspects, new results from studies, which might change treatment recommendations and long-term-survivorship: Is there still an indication for radiotherapy in seminoma CS I/ IIA/B?- How should we treat nonseminoma CSI? -- Is there still an indication for diagnostic RPLND in nonseminoma CSI? -- How could the prognosis of patients with intermediate risk disease be improved? -- How should patients with poor-prognosis disease be treated actually? -- How should patients with recurrent disease be treated actually? -- How important are prognostic factors for determining treatment in patients with primary or recurrent disease? -- What should be the boundaries in retroperitoneal residual tumor resection in nonseminoma? -- How should residual disease outside the retroperitoneum be treated? -- What are the recent recommendations for follow up in testicular cancer? -- What are the long-term toxicities to be controlled and treated? -- Consequences of the disease and its treatment concerning sexuality and fertility |
| Beschreibung: | 1 Online Ressource (VIII, 135 Seiten, 9 Illustrationen in Farbe) |
| ISBN: | 9783319174679 |
| DOI: | 10.1007/978-3-319-17467-9 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV046812923 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 200717s2015 |||| o||u| ||||||eng d | ||
| 020 | |a 9783319174679 |9 978-3-319-17467-9 | ||
| 024 | 7 | |a 10.1007/978-3-319-17467-9 |2 doi | |
| 035 | |a (ZDB-2-SME)978-3-319-17467-9 | ||
| 035 | |a (OCoLC)1190920196 | ||
| 035 | |a (DE-599)BVBBV046812923 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.994 | |
| 245 | 1 | 0 | |a Diagnosis and Management of Testicular Cancer |b The European Point of View |c edited by Susanne Krege |
| 250 | |a 1st ed. 2015 | ||
| 264 | 1 | |a Cham |b Springer International Publishing |c 2015 | |
| 300 | |a 1 Online Ressource (VIII, 135 Seiten, 9 Illustrationen in Farbe) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Part I: Overview of the latest recommendations of the European Germ Cell Cancer Group -- Part II: Special topics about controversial aspects, new results from studies, which might change treatment recommendations and long-term-survivorship: Is there still an indication for radiotherapy in seminoma CS I/ IIA/B?- How should we treat nonseminoma CSI? -- Is there still an indication for diagnostic RPLND in nonseminoma CSI? -- How could the prognosis of patients with intermediate risk disease be improved? -- How should patients with poor-prognosis disease be treated actually? -- How should patients with recurrent disease be treated actually? -- How important are prognostic factors for determining treatment in patients with primary or recurrent disease? -- What should be the boundaries in retroperitoneal residual tumor resection in nonseminoma? -- How should residual disease outside the retroperitoneum be treated? -- What are the recent recommendations for follow up in testicular cancer? -- What are the long-term toxicities to be controlled and treated? -- Consequences of the disease and its treatment concerning sexuality and fertility | ||
| 520 | |a This book presents the views of leading European experts on the diagnosis and management of testicular cancer, with coverage of current hot topics in the field. It opens by providing an overview of the recommendations in the most recent consensus paper from the European Germ Cell Cancer Consensus Group, which is based on interdisciplinary cooperation among urologists, medical oncologists, radio-oncologists, pathologists, and basic scientists. The remainder of the book focuses on areas of controversy in the diagnosis, treatment, and follow-up of testicular cancer. In each case the evidence base is discussed and results from the most recent studies are reviewed, drawing attention to new findings that might alter treatment recommendations. The treatment-related chapters cover a broad range of issues, including the best approach in patients with poor-prognosis and recurrent disease and those with long-term toxicities. Relevant aspects of survivorship care are also addressed. The book will help clinicians and practitioners to achieve the goals of minimizing therapy and its side-effects without reducing efficacy in low stage disease, improving the cure rate in advanced disease, and enhancing follow-up and long-term survivorship | ||
| 650 | 4 | |a Oncology | |
| 650 | 4 | |a Urology | |
| 650 | 4 | |a Surgery | |
| 650 | 4 | |a Radiotherapy | |
| 700 | 1 | |a Krege, Susanne |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783319174662 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783319174686 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783319359632 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-319-17467-9 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_2015 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032221438 | ||
| 966 | e | |u https://doi.org/10.1007/978-3-319-17467-9 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_2015 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804181619884425216 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| building | Verbundindex |
| bvnumber | BV046812923 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-3-319-17467-9 (OCoLC)1190920196 (DE-599)BVBBV046812923 |
| dewey-full | 616.994 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.994 |
| dewey-search | 616.994 |
| dewey-sort | 3616.994 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| doi_str_mv | 10.1007/978-3-319-17467-9 |
| edition | 1st ed. 2015 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03967nmm a2200457zc 4500</leader><controlfield tag="001">BV046812923</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">200717s2015 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783319174679</subfield><subfield code="9">978-3-319-17467-9</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-319-17467-9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-319-17467-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1190920196</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046812923</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.994</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Diagnosis and Management of Testicular Cancer</subfield><subfield code="b">The European Point of View</subfield><subfield code="c">edited by Susanne Krege</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st ed. 2015</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham</subfield><subfield code="b">Springer International Publishing</subfield><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online Ressource (VIII, 135 Seiten, 9 Illustrationen in Farbe)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Part I: Overview of the latest recommendations of the European Germ Cell Cancer Group -- Part II: Special topics about controversial aspects, new results from studies, which might change treatment recommendations and long-term-survivorship: Is there still an indication for radiotherapy in seminoma CS I/ IIA/B?- How should we treat nonseminoma CSI? -- Is there still an indication for diagnostic RPLND in nonseminoma CSI? -- How could the prognosis of patients with intermediate risk disease be improved? -- How should patients with poor-prognosis disease be treated actually? -- How should patients with recurrent disease be treated actually? -- How important are prognostic factors for determining treatment in patients with primary or recurrent disease? -- What should be the boundaries in retroperitoneal residual tumor resection in nonseminoma? -- How should residual disease outside the retroperitoneum be treated? -- What are the recent recommendations for follow up in testicular cancer? -- What are the long-term toxicities to be controlled and treated? -- Consequences of the disease and its treatment concerning sexuality and fertility</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This book presents the views of leading European experts on the diagnosis and management of testicular cancer, with coverage of current hot topics in the field. It opens by providing an overview of the recommendations in the most recent consensus paper from the European Germ Cell Cancer Consensus Group, which is based on interdisciplinary cooperation among urologists, medical oncologists, radio-oncologists, pathologists, and basic scientists. The remainder of the book focuses on areas of controversy in the diagnosis, treatment, and follow-up of testicular cancer. In each case the evidence base is discussed and results from the most recent studies are reviewed, drawing attention to new findings that might alter treatment recommendations. The treatment-related chapters cover a broad range of issues, including the best approach in patients with poor-prognosis and recurrent disease and those with long-term toxicities. Relevant aspects of survivorship care are also addressed. The book will help clinicians and practitioners to achieve the goals of minimizing therapy and its side-effects without reducing efficacy in low stage disease, improving the cure rate in advanced disease, and enhancing follow-up and long-term survivorship</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology </subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Urology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Surgery</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Radiotherapy</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Krege, Susanne</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783319174662</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783319174686</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783319359632</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-319-17467-9</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_2015</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032221438</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-319-17467-9</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_2015</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV046812923 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T14:59:20Z |
| indexdate | 2024-07-10T08:54:32Z |
| institution | BVB |
| isbn | 9783319174679 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032221438 |
| oclc_num | 1190920196 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online Ressource (VIII, 135 Seiten, 9 Illustrationen in Farbe) |
| psigel | ZDB-2-SME ZDB-2-SME_2015 ZDB-2-SME ZDB-2-SME_2015 |
| publishDate | 2015 |
| publishDateSearch | 2015 |
| publishDateSort | 2015 |
| publisher | Springer International Publishing |
| record_format | marc |
| spelling | Diagnosis and Management of Testicular Cancer The European Point of View edited by Susanne Krege 1st ed. 2015 Cham Springer International Publishing 2015 1 Online Ressource (VIII, 135 Seiten, 9 Illustrationen in Farbe) txt rdacontent c rdamedia cr rdacarrier Part I: Overview of the latest recommendations of the European Germ Cell Cancer Group -- Part II: Special topics about controversial aspects, new results from studies, which might change treatment recommendations and long-term-survivorship: Is there still an indication for radiotherapy in seminoma CS I/ IIA/B?- How should we treat nonseminoma CSI? -- Is there still an indication for diagnostic RPLND in nonseminoma CSI? -- How could the prognosis of patients with intermediate risk disease be improved? -- How should patients with poor-prognosis disease be treated actually? -- How should patients with recurrent disease be treated actually? -- How important are prognostic factors for determining treatment in patients with primary or recurrent disease? -- What should be the boundaries in retroperitoneal residual tumor resection in nonseminoma? -- How should residual disease outside the retroperitoneum be treated? -- What are the recent recommendations for follow up in testicular cancer? -- What are the long-term toxicities to be controlled and treated? -- Consequences of the disease and its treatment concerning sexuality and fertility This book presents the views of leading European experts on the diagnosis and management of testicular cancer, with coverage of current hot topics in the field. It opens by providing an overview of the recommendations in the most recent consensus paper from the European Germ Cell Cancer Consensus Group, which is based on interdisciplinary cooperation among urologists, medical oncologists, radio-oncologists, pathologists, and basic scientists. The remainder of the book focuses on areas of controversy in the diagnosis, treatment, and follow-up of testicular cancer. In each case the evidence base is discussed and results from the most recent studies are reviewed, drawing attention to new findings that might alter treatment recommendations. The treatment-related chapters cover a broad range of issues, including the best approach in patients with poor-prognosis and recurrent disease and those with long-term toxicities. Relevant aspects of survivorship care are also addressed. The book will help clinicians and practitioners to achieve the goals of minimizing therapy and its side-effects without reducing efficacy in low stage disease, improving the cure rate in advanced disease, and enhancing follow-up and long-term survivorship Oncology Urology Surgery Radiotherapy Krege, Susanne Sonstige oth Erscheint auch als Druck-Ausgabe 9783319174662 Erscheint auch als Druck-Ausgabe 9783319174686 Erscheint auch als Druck-Ausgabe 9783319359632 https://doi.org/10.1007/978-3-319-17467-9 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Diagnosis and Management of Testicular Cancer The European Point of View Oncology Urology Surgery Radiotherapy |
| title | Diagnosis and Management of Testicular Cancer The European Point of View |
| title_auth | Diagnosis and Management of Testicular Cancer The European Point of View |
| title_exact_search | Diagnosis and Management of Testicular Cancer The European Point of View |
| title_exact_search_txtP | Diagnosis and Management of Testicular Cancer The European Point of View |
| title_full | Diagnosis and Management of Testicular Cancer The European Point of View edited by Susanne Krege |
| title_fullStr | Diagnosis and Management of Testicular Cancer The European Point of View edited by Susanne Krege |
| title_full_unstemmed | Diagnosis and Management of Testicular Cancer The European Point of View edited by Susanne Krege |
| title_short | Diagnosis and Management of Testicular Cancer |
| title_sort | diagnosis and management of testicular cancer the european point of view |
| title_sub | The European Point of View |
| topic | Oncology Urology Surgery Radiotherapy |
| topic_facet | Oncology Urology Surgery Radiotherapy |
| url | https://doi.org/10.1007/978-3-319-17467-9 |
| work_keys_str_mv | AT kregesusanne diagnosisandmanagementoftesticularcancertheeuropeanpointofview |